Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors

被引:33
|
作者
Hernandez, Silvia
Toll, Agusti
Baselga, Eulalia
Ribe, Adriana
Azua-Romeo, Javier
Pujol, Ramon M.
Real, Francisco X.
机构
[1] Inst Municipal Invest Med, Unitat Biol Celular & Mol, E-08003 Barcelona, Spain
[2] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[3] Univ Zaragoza, Dept Anat & Histol, Barcelona, Spain
[4] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[5] Hosp del Mar, Serv Dermatol, Barcelona, Spain
[6] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain
关键词
D O I
10.1038/sj.jid.5700705
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Epidermal nevi (EN) are benign lesions presenting at birth or in childhood. Based on the occurrence of fibroblast growth factor receptor 3 (,FGFR3) mutations in seborrheic keratosis and urothelial carcinomas (UC), and the identification of two young patients with EN and UC, we hypothesized that mutations might occur in EN. The R248C mutation was found in 6/23 (26.1%) EN but it was absent from unaffected skin. In two patients with EN and UC, both lesions were FGFR3 wild type. Our findings indicate that: (1) FGFR3 mutations occur in mosaicism and can cause EN and (2) other genes are involved in EN.
引用
收藏
页码:1664 / 1666
页数:3
相关论文
共 50 条
  • [1] Fibroblast growth factor receptor 3 mutations in bladder tumors correlate with low frequency of chromosome alterations
    Junker, Kerstin
    van Oers, Johanna M. M.
    Zwarthoff, Ellen
    Kania, Ines
    Schubert, Joerg
    Hartmann, Arndt
    NEOPLASIA, 2008, 10 (01): : 1 - 7
  • [2] Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors
    Zieger, K
    Dyrskjot, L
    Wiuf, C
    Jensen, JL
    Andersen, CL
    Jensen, KME
    Orntoft, TF
    CLINICAL CANCER RESEARCH, 2005, 11 (21) : 7709 - 7719
  • [3] Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer
    Poyet, Cedric
    Hermanns, Thomas
    Zhong, Qing
    Drescher, Eva
    Eberli, Daniel
    Burger, Maximilian
    Hofstaedter, Ferdinand
    Hartmann, Arndt
    Stoehr, Robert
    Zwarthoff, Ellen C.
    Sulser, Tullio
    Wild, Peter J.
    ONCOLOGY LETTERS, 2015, 10 (05) : 2753 - 2760
  • [4] Identification of epidermal growth factor receptor mutations in bladder cancer
    Jacobs, MA
    Wotkowicz, C
    Baumgart, ED
    Rieger-Christ, KM
    Libertino, JA
    Summerhayes, IC
    JOURNAL OF UROLOGY, 2006, 175 (04): : 203 - 203
  • [5] The role of mutations and overexpression of the fibroblast growth factor receptor-3 in bladder cancer
    Wang, Q. Y.
    Zhao, Y.
    Zhang, R.
    MINERVA MEDICA, 2015, 106 (06) : 333 - 337
  • [6] Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers
    Jang, JH
    Shin, KH
    Park, JG
    CANCER RESEARCH, 2001, 61 (09) : 3541 - 3543
  • [7] Skeletal disorders associated with fibroblast growth factor receptor mutations
    DeMoerlooze, L
    Dickson, C
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 1997, 7 (03) : 378 - 385
  • [8] Fibroblast growth factor receptors as candidates for mutation in linear epidermal nevi
    Munro, CS
    Moss, C
    Wilkie, OM
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 593 - 593
  • [9] Epidermal Growth Factor Receptor Mutations
    McLoughlin, Erin M.
    Gentzler, Ryan D.
    THORACIC SURGERY CLINICS, 2020, 30 (02) : 127 - 136
  • [10] EPIDERMAL GROWTH FACTOR RECEPTOR GENE STATUS IN BORDERLINE OVARIAN TUMORS AND LOW GRADE SEROUS CARCINOMA
    Showeil, R.
    Petrizan, M. Valganon
    Romano, C.
    Osborne, R.
    Foroni, L.
    El Bahrawy, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)